IMDX
Insight Molecular Diagnostics Inc. Common StockIMDX
IMDX
0
Funds holding %
of 7,302 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
146% more capital invested
Capital invested by funds: $20M [Q4 2024] → $49.2M (+$29.2M) [Q1 2025]
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
15% more funds holding
Funds holding: 26 [Q4 2024] → 30 (+4) [Q1 2025]
6.29% more ownership
Funds ownership: 49.97% [Q4 2024] → 56.27% (+6.29%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for IMDX.
Financial journalist opinion
We haven’t received any recent news articles for IMDX.
Charts implemented using Lightweight Charts™